Xu, Zhen-dong
Wang, Yong
Liang, Ge
Liu, Zhi-qiang
Ma, Wu-hua
Chu, Charleen T
Wei, Hua-feng
Article History
Received: 12 April 2019
Accepted: 29 August 2019
First Online: 23 October 2019
Competing interests
: Hua-feng Wei is a member of Advisory Board on March 10, 2017 at Eagle Pharmaceutical Company, New Jersey, USA, which produce and sale Ryanodex, a new formula of dantrolene. The dantrolene used in this study was purchased from a different company. No other authors state conflict of interest.